Alpha Cognition announces bioequivalence study results for Alzheimer’s
In 2019, there were over 850,000 people with dementia in the UK, representing one in every 14 people aged 65 and over
Read More
Tag: Alpha Cognition
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
